Browse Pet Safety Reports
15,441 FDA adverse event reports for pets.
FDA Veterinary Adverse Event Database
Browse 15,441 adverse event reports collected by the FDA's Center for Veterinary Medicine. Each report includes the animal species, breed, drug or product involved, observed reactions, and outcome. Reports flagged as "serious" involve death, life-threatening conditions, or hospitalization. Use the filters to narrow results by species, outcome severity, or keyword. Note that a higher number of reports does not necessarily indicate a less safe product — widely prescribed drugs naturally accumulate more reports.
Pet Adverse Event Reports
Browse 15,441 FDA veterinary adverse event reports.
| Date | Species | Breed | Drug | Reaction | Outcome |
|---|---|---|---|---|---|
| May 16, 2017 | Dog | Shepherd Dog - German | Ivermectin; Pyrantel As Pamoate Salt | Appetite loss; Drinking a lot; Lack of coordination (see also 'Ear' - vestibu... | Died |
| May 16, 2017 | Dog | Hound - Basset | Afoxolaner | Vomiting; Lethargy (see also Central nervous system depression in 'Neurologic... | Died |
| May 16, 2017 | Dog | Retriever - Labrador, Dog (... | Polysulfated Glycosaminoglycan | Anorexia; Pale mucous membrane; Dehydration; Muscle weakness NOS; Propriocept... | Died |
| May 16, 2017 | Dog | Dachshund - Standard Smooth... | Trilostane | Limb weakness; Proteinuria; Haematuria; Pyuria; Elevated serum alkaline phosp... | Outcome Unknown |
| May 15, 2017 | Dog | Shepherd Dog - German, Dog ... | Carprofen | Vomiting; Diarrhoea; Hypersalivation; Lethargy (see also Central nervous syst... | Recovered/Normal |
| May 15, 2017 | Dog | Dog (unknown) | Trilostane | Generalised weakness; Lethargy (see also Central nervous system depression in... | Outcome Unknown |
| May 14, 2017 | Dog | Retriever - Golden | Maropitant Citrate | Lameness; Limb weakness; Stiffness NOS; Joint effusion; Discoloured urine; Jo... | Died |
| May 13, 2017 | Dog | Retriever - Golden | Grapiprant | Generalised weakness; Anorexia; Hypoglycaemia; Elevated blood urea nitrogen (... | Euthanized |
| May 12, 2017 | Dog | Boxer (German Boxer) | Sarolaner | Tremor; Abnormal posture; Seizure NOS; Limb weakness | Outcome Unknown |
| May 12, 2017 | Dog | Crossbred Canine/dog | Oclacitinib Maleate | Lethargy (see also Central nervous system depression in 'Neurological'); Weak... | Ongoing |
| May 11, 2017 | Dog | Hound (unspecified) | Moxidectin | Anaphylaxis; Collapse NOS (see also 'Cardio-vascular' and 'Neurological disor... | Ongoing |
| May 11, 2017 | Dog | Retriever - Labrador | Fluralaner Chew Tablets | Seizure NOS; Death by euthanasia; Weakness; Mental impairment NOS; Heart valv... | Euthanized |
| May 10, 2017 | Dog | Pug | Afoxolaner | Lethargy (see also Central nervous system depression in 'Neurological'); Limb... | Recovered/Normal |
| May 10, 2017 | Cat | Cat (other) | Selamectin | Limb weakness; Walking difficulty | Outcome Unknown |
| May 10, 2017 | Cat | Domestic Shorthair | Fluralaner Spot-On Solution | Weakness; Lethargy (see also Central nervous system depression in 'Neurologic... | Recovered/Normal |
| May 10, 2017 | Dog | Terrier - Jack Russell | Moxidectin | Decreased appetite; Lethargy (see also Central nervous system depression in '... | Ongoing |
| May 7, 2017 | Dog | Crossbred Canine/dog | Firocoxib | Mouth blister; Panting; Lethargy (see also Central nervous system depression ... | Euthanized |
| May 7, 2017 | Cat | Domestic Shorthair | Selamectin | Lethargy (see also Central nervous system depression in 'Neurological'); Foun... | Died |
| May 7, 2017 | Dog | Schnauzer - Miniature | Trilostane | Lethargy (see also Central nervous system depression in 'Neurological'); Musc... | Euthanized |
| May 7, 2017 | Cat | Domestic Shorthair | Cefovecin | Lethargy (see also Central nervous system depression in 'Neurological'); Pale... | Euthanized |
| May 6, 2017 | Dog | Terrier - Bull - American P... | Moxidectin | General illness; Weakness; Reluctant to move | Recovered/Normal |
| May 6, 2017 | Dog | Retriever - Labrador | Sulfadimethoxine | Anaemia NOS; Collapse (see also 'Cardio-vascular' and 'Systemic disorders'); ... | Euthanized |
| May 5, 2017 | Dog | Retriever - Labrador | Afoxolaner | Ataxia; Lethargy (see also Central nervous system depression in 'Neurological... | Outcome Unknown |
| May 4, 2017 | Dog | Terrier - Jack Russell | Trilostane | Vomiting; Shaking; Diarrhoea; Weakness | Recovered/Normal |
| May 4, 2017 | Dog | Shepherd Dog - German | Afoxolaner | Disorientation; Weakness; Vomiting; Other abnormal test result NOS; Elevated ... | Outcome Unknown |
| May 3, 2017 | Dog | Retriever - Labrador | Moxidectin | Vomiting; Weakness; Lethargy (see also Central nervous system depression in '... | Ongoing |
| May 3, 2017 | Dog | Spaniel (unspecified) | Sarolaner | Trembling; Systemic disorder NOS; Weakness; Scratching; Seizure NOS; Lack of ... | Recovered/Normal |
| May 2, 2017 | Dog | Crossbred Canine/dog | Milbemycin Oxime; Praziquantel | Lethargy (see also Central nervous system depression in 'Neurological'); Weak... | Outcome Unknown |
| May 2, 2017 | Dog | Shih Tzu, Poodle - Miniature | Afoxolaner | Seizure NOS; Stiffness NOS; Twitching; Lethargy (see also Central nervous sys... | Outcome Unknown |
| May 2, 2017 | Dog | Chow Chow, Crossbred Canine... | Grapiprant | Lethargy (see also Central nervous system depression in 'Neurological'); Musc... | Recovered/Normal |
| May 2, 2017 | Dog | Dachshund (unspecified) | Fluralaner Chew Tablets | Tremor; Anorexia; Limb weakness | Ongoing |
| May 2, 2017 | Dog | Poodle - Miniature | Fluralaner Chew Tablets | Generalised weakness; Leucocytosis NOS; Neutrophilia | Ongoing |
| May 1, 2017 | Dog | Terrier - Irish | Oclacitinib Maleate | Anorexia; Lethargy (see also Central nervous system depression in 'Neurologic... | Ongoing |
| May 1, 2017 | Dog | Retriever - Labrador, Dog (... | Oclacitinib Maleate | Welt; Local swelling (not application site); Pinnal oedema; Elevated temperat... | Died |
| May 1, 2017 | Dog | Sheepdog - Shetland | Afoxolaner | Itching; Reddening of the skin; Hives (see also 'Skin'); Limb weakness | Outcome Unknown |
| May 1, 2017 | Dog | Terrier - Yorkshire, Poodle... | Imidacloprid; Moxidectin | Lethargy (see also Central nervous system depression in 'Neurological'); Late... | Outcome Unknown |
| Apr 29, 2017 | Dog | Schipperke, Crossbred Canin... | Trilostane | Shallow breathing; Ataxia; Weakness; Trembling; Hypocalcaemic condition; Hypo... | Euthanized |
| Apr 28, 2017 | Dog | Bloodhound | Selamectin | Collapse NOS (see also 'Cardio-vascular' and 'Neurological disorders'); Unres... | Recovered/Normal |
| Apr 28, 2017 | Dog | Retriever - Labrador | Carprofen | Limb weakness; Hind limb paralysis | Ongoing |
| Apr 27, 2017 | Dog | Bulldog - American | Cyclosporine | Lameness; Weight gain; Localised hair loss; Muscle weakness NOS | Ongoing |
| Apr 26, 2017 | Dog | Mountain Dog - Bernese, Dog... | Sarolaner | Limb weakness | Recovered/Normal |
| Apr 26, 2017 | Dog | Spitz - German Pomeranian, ... | Sarolaner | Tremor; Weakness | Ongoing |
| Apr 26, 2017 | Cat | Domestic Longhair | Pyrantel Pamoate (Pyrantel Embonate) | Increased bowel movements (frequency); Walking difficulty; Decreased activity... | Died |
| Apr 26, 2017 | Dog | Terrier - Bull - American Pit | Sarolaner | Diarrhoea; Increased bowel movements (frequency); Weakness; Uncomfortable | Ongoing |
| Apr 25, 2017 | Dog | Terrier - Bull - Staffordshire | Trilostane | Weakness; Decreased appetite; Electrolyte disorder; Hyperkalaemia; Muscle was... | Ongoing |
| Apr 24, 2017 | Dog | Boxer (German Boxer) | Melarsomine Dihydrochloride Injection | Cyanosis; Papular rash; Generalised weakness; Circulatory collapse (see also ... | Recovered/Normal |
| Apr 24, 2017 | Dog | Beagle | Oclacitinib Maleate | Weakness; Unsteady gait | Recovered/Normal |
| Apr 23, 2017 | Dog | Poodle (unspecified), Bicho... | Spinosad; Milbemycin Oxime | Lethargy (see also Central nervous system depression in 'Neurological'); Droo... | Recovered/Normal |
| Apr 23, 2017 | Dog | Terrier - Boston | Carprofen | Incoordination; Shaking; Weakness; Musculoskeletal disorder NOS | Ongoing |
| Apr 21, 2017 | Dog | Hound (unspecified) | Oclacitinib Maleate | Muscle weakness NOS; Systemic disorder NOS; Pancreatitis | Ongoing |
Frequently Asked Questions
Contact your veterinarian immediately. If the reaction is severe — difficulty breathing, seizures, collapse, or severe swelling — seek emergency veterinary care right away. After your pet is stabilized, report the adverse event to the FDA through safetyreporting.hhs.gov or by calling 1-888-FDA-VETS (1-888-332-8387). Reporting helps the FDA identify safety issues that can lead to label changes or product recalls.
Dogs account for the majority of adverse event reports, followed by cats. This reflects both the larger pet population and wider range of medications for these species. Flea and tick products, pain medications (NSAIDs), and heartworm preventives are among the product categories with the highest report counts across all species.
Not necessarily. A drug used by millions of pets will have more reports in absolute numbers than a niche product, even if the actual rate of adverse events is lower. The FDA uses these reports as one of many tools to evaluate drug safety, looking for patterns and statistical signals rather than raw counts alone. Always consult your veterinarian before changing any medication.